A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants with Relapsing Forms of Multiple Sclerosis (RMS) or Progressive Forms of Multiple Sclerosis (PMS)
Details
Age
Adult
Locations
Brain Imaging Center (BIC) - Scan Read
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Amanda Piquet
Study ID
Protocol Number: 23-1992
More information available at ClinicalTrials.gov: NCT06220201
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers